Coordinated CROWD4ROADS, developing crowd-sourced road monitoring and ride-sharing solutions for sustainable transport.
Universita' degli Studi di Urbino Carlo Bo
Italian university with cross-disciplinary H2020 experience in drug discovery, citizen science, smart mobility, and agri-environment research.
Their core work
The University of Urbino Carlo Bo is a mid-sized Italian public university with research groups active across drug discovery, citizen science, and digital mobility solutions. Their pharmaceutical research focuses on allosteric drug design — finding new ways to inhibit disease-related proteins by targeting sites other than the active site. In parallel, they have built competence in crowd-sourced data collection for road infrastructure monitoring and sustainable transport. More recently, they contribute to large European research infrastructure clusters in astronomy and particle physics, particularly around open science and data management.
What they specialise in
Participates in ALLODD, contributing to structure-based drug design targeting allosteric inhibitors.
Participated in IEDAT, a clinical project on intra-erythrocyte dexamethasone treatment for Ataxia Telangiectasia.
Third-party contributor to ESCAPE, supporting citizen science and open data for major ESFRI astronomy and particle physics facilities.
Participates in SHOWCASE, working on economic incentives and knowledge exchange to link agriculture with biodiversity conservation.
How they've shifted over time
In the earlier period (2016–2019), Urbino's H2020 work centered on applied digital solutions — crowd sensing, road monitoring, and ride-sharing platforms — with CROWD4ROADS being their only coordinated project. From 2019 onward, they pivoted sharply toward open science, large-scale research infrastructures (ESCAPE), biodiversity-agriculture links (SHOWCASE), and pharmaceutical research (ALLODD). The shift suggests a university broadening from niche applied ICT into fundamental science support roles and life sciences.
Urbino is moving from applied ICT coordination toward specialized contributor roles in life sciences and large research infrastructure networks — expect future involvement in open science, pharmaceutical, or environmental projects rather than digital platform development.
How they like to work
With only one project as coordinator and three as participant, Urbino primarily joins consortia led by others, contributing domain-specific expertise rather than driving project design. Their 83 unique partners across 18 countries indicate broad but shallow networking — they rarely repeat partnerships, instead plugging into different communities per project. This makes them a flexible, low-friction partner to onboard but not a consortium-building hub.
Urbino has collaborated with 83 distinct partners across 18 countries, reflecting a wide but non-concentrated European network. Their involvement in ESCAPE alone connects them to major research infrastructure organizations (CERN, ESO, JIVE), giving them indirect access to the top-tier physics and astronomy community.
What sets them apart
Urbino's unusual combination of pharmaceutical drug design, citizen science, and crowd-sourced mobility research is rare for a university of its size. Their ESCAPE involvement gives them a direct line into Europe's largest physics and astronomy infrastructure cluster, which most universities outside the top tier do not have. For a consortium builder, they offer a reliable Italian academic partner with genuine cross-disciplinary reach and no heavy coordination overhead.
Highlights from their portfolio
- CROWD4ROADSTheir only coordinated project (EUR 384K), combining crowd sensing with ride-sharing for road sustainability — a distinctive applied ICT topic for a traditional university.
- ESCAPEConnects Urbino to CERN, ESO, and major ESFRI infrastructures in astronomy and particle physics, vastly expanding their network beyond their typical scale.
- ALLODDAn MSCA training network on allosteric drug discovery, signaling a serious investment in next-generation pharmaceutical research talent.